We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BIIB market cap is 31.34B. The company's latest EPS is USD 7.9877 and P/E is 27.00.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 2.54B | 2.46B | 2.46B | 2.53B | 2.39B |
Operating Income | 556.7M | 507.7M | 643.8M | 44.8M | 775.7M |
Net Income | 550.4M | 387.9M | 591.6M | -68.1M | 249.7M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 14.44B | 13.62B | 11.03B | 10.17B | 9.84B |
Operating Income | 7.04B | 4.55B | 3.09B | 2.76B | 2.03B |
Net Income | 5.89B | 4B | 1.81B | 3.05B | 1.16B |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 24.55B | 24.6B | 25.16B | 28.19B | 26.84B |
Total Liabilities | 11.17B | 10.81B | 10.7B | 13.71B | 12.05B |
Total Equity | 13.39B | 13.79B | 14.46B | 14.48B | 14.8B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 27.23B | 24.62B | 23.88B | 24.55B | 26.84B |
Total Liabilities | 13.9B | 13.93B | 12.92B | 11.17B | 12.05B |
Total Equity | 13.34B | 10.69B | 10.96B | 13.39B | 14.8B |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 1.38B | 455.3M | 942.3M | 1.53B | 1.55B |
Investing | 1.58B | -953M | -1.71B | -3.45B | -4.1B |
Financing | -1.75B | -43.4M | -53.2M | 795.4M | 149.3M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 7.08B | 4.23B | 3.64B | 1.38B | 1.55B |
Investing | 470.5M | -608.6M | -563.7M | 1.58B | -4.1B |
Financing | -5.86B | -5.27B | -2.09B | -1.75B | 149.3M |
Market Cap | 31.34B |
Price to Earnings Ratio | 27.00 |
Price to Sales Ratio | 3.19 |
Price to Cash Ratio | 29.85 |
Price to Book Ratio | 2.12 |
Dividend Yield | - |
Shares Outstanding | 145.36M |
Average Volume (1 week) | 1.13M |
Average Volume (1 Month) | 1.33M |
52 Week Change | -20.16% |
52 Week High | 319.76 |
52 Week Low | 211.015 |
Spread (Intraday) | 4.12 (1.91%) |
Company Name | Biogen Inc |
Address |
3411 silverside road tatnall wilmington, delaware 19810 |
Website | https://www.biogen.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions